{"id":"metronidazole-male-partner","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Metallic taste"},{"rate":"5-15","effect":"Nausea"},{"rate":"5-10","effect":"Headache"},{"rate":"5-10","effect":"Gastrointestinal upset"},{"rate":"null","effect":"Dark urine"}]},"_chembl":{"chemblId":"CHEMBL137","moleculeType":"Small molecule","molecularWeight":"171.16"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Metronidazole is activated by anaerobic organisms and generates cytotoxic free radicals that damage microbial DNA, leading to cell death. It is effective against anaerobic bacteria and certain parasites. In this Phase 3 trial context (male partner treatment), it is likely being used to treat bacterial vaginosis or trichomoniasis in the female partner's male sexual contact to prevent reinfection.","oneSentence":"Metronidazole is a nitroimidazole antibiotic that disrupts bacterial and parasitic DNA by generating reactive oxygen species after being reduced in anaerobic environments.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:21:05.163Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial vaginosis (male partner treatment to prevent reinfection)"},{"name":"Trichomoniasis (male partner treatment)"}]},"trialDetails":[{"nctId":"NCT02209519","phase":"PHASE3","title":"Randomized Controlled Trial of Treatment of Male Partners of Women With BV","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2015-02","conditions":"Recurrent Bacterial Vaginosis","enrollment":214}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":13,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Metronidazole (male partner)","genericName":"Metronidazole (male partner)","companyName":"University of Alabama at Birmingham","companyId":"university-of-alabama-at-birmingham","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Metronidazole is a nitroimidazole antibiotic that disrupts bacterial and parasitic DNA by generating reactive oxygen species after being reduced in anaerobic environments. Used for Bacterial vaginosis (male partner treatment to prevent reinfection), Trichomoniasis (male partner treatment).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}